BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22634495)

  • 1. MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells.
    Long MJ; Wu FX; Li P; Liu M; Li X; Tang H
    Cancer Lett; 2012 Nov; 324(2):186-96. PubMed ID: 22634495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-590 promotes cervical cancer cell growth and invasion by targeting CHL1.
    Chu Y; Ouyang Y; Wang F; Zheng A; Bai L; Han L; Chen Y; Wang H
    J Cell Biochem; 2014 May; 115(5):847-53. PubMed ID: 24288179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells.
    Qiang R; Wang F; Shi LY; Liu M; Chen S; Wan HY; Li YX; Li X; Gao SY; Sun BC; Tang H
    Int J Biochem Cell Biol; 2011 Apr; 43(4):632-41. PubMed ID: 21216304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal.
    Luo L; Ye G; Nadeem L; Fu G; Yang BB; Honarparvar E; Dunk C; Lye S; Peng C
    J Cell Sci; 2012 Jul; 125(Pt 13):3124-32. PubMed ID: 22454525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells.
    Yao Q; Xu H; Zhang QQ; Zhou H; Qu LH
    Biochem Biophys Res Commun; 2009 Oct; 388(3):539-42. PubMed ID: 19682430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
    Luo M; Shen D; Zhou X; Chen X; Wang W
    Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
    Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
    Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma.
    Xu X; Chen Z; Zhao X; Wang J; Ding D; Wang Z; Tan F; Tan X; Zhou F; Sun J; Sun N; Gao Y; Shao K; Li N; Qiu B; He J
    Biochem Biophys Res Commun; 2012 May; 421(4):640-5. PubMed ID: 22450326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells.
    Kang HW; Wang F; Wei Q; Zhao YF; Liu M; Li X; Tang H
    FEBS Lett; 2012 Mar; 586(6):897-904. PubMed ID: 22449978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-10a controls glioma migration and invasion through regulating epithelial-mesenchymal transition via EphA8.
    Yan Y; Wang Q; Yan XL; Zhang Y; Li W; Tang F; Li X; Yang P
    FEBS Lett; 2015 Mar; 589(6):756-65. PubMed ID: 25683004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.
    Kinoshita T; Nohata N; Watanabe-Takano H; Yoshino H; Hidaka H; Fujimura L; Fuse M; Yamasaki T; Enokida H; Nakagawa M; Hanazawa T; Okamoto Y; Seki N
    Int J Oncol; 2012 Jun; 40(6):1770-8. PubMed ID: 22378351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.
    Fuse M; Nohata N; Kojima S; Sakamoto S; Chiyomaru T; Kawakami K; Enokida H; Nakagawa M; Naya Y; Ichikawa T; Seki N
    Int J Oncol; 2011 Apr; 38(4):1093-101. PubMed ID: 21258769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.
    Fan Z; Cui H; Xu X; Lin Z; Zhang X; Kang L; Han B; Meng J; Yan Z; Yan X; Jiao S
    Oncotarget; 2015 Sep; 6(28):25266-80. PubMed ID: 26389681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
    Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
    Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328.
    Paduano F; Dattilo V; Narciso D; Bilotta A; Gaudio E; Menniti M; Agosti V; Palmieri C; Perrotti N; Fusco A; Trapasso F; Iuliano R
    FEBS J; 2013 Jan; 280(2):401-12. PubMed ID: 22564856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
    Liu M; Lang N; Chen X; Tang Q; Liu S; Huang J; Zheng Y; Bi F
    Cancer Lett; 2011 Feb; 301(2):151-60. PubMed ID: 21186079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
    Wang N; Zhou Y; Zheng L; Li H
    Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.
    Qin W; Ren Q; Liu T; Huang Y; Wang J
    FEBS Lett; 2013 May; 587(9):1434-9. PubMed ID: 23523916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion.
    Li Q; Wang G; Shan JL; Yang ZX; Wang HZ; Feng J; Zhen JJ; Chen C; Zhang ZM; Xu W; Luo XZ; Wang D
    J Gastroenterol Hepatol; 2010 Jan; 25(1):164-71. PubMed ID: 19793168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-433 inhibits cervical cancer progression by directly targeting metadherin to regulate the AKT and β-catenin signalling pathways.
    Liang C; Ding J; Yang Y; Deng L; Li X
    Oncol Rep; 2017 Dec; 38(6):3639-3649. PubMed ID: 29130111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.